German competition regulator clears path for Novartis takeover of MorphoSys

Morphosys AG

12/03/2024 09:31

March 12 (Reuters) - Germany's antitrust regulator on
Tuesday said it approved the planned takeover of all shares in
MorphoSys  MORG.DE , a developer of cancer treatments, by
Switzerland's Novartis.  NOVN.S 
    "We checked very carefully that the merger would not affect
competition for research and development of new drugs against a
form of leukemia," Andreas Mundt, President of the Federal
Cartel Office said.

 (Reporting by Bartosz Dabrowski in Gdansk
Editing by Madeline Chambers)
 ((bartosz.dabrowski@thomsonreuters.com; +48 58 7696560;))